Taken together, we were convinced that METTL14 exerted its anti-metastatic function and its inhibitory effect on the PI3K/AKT signal as well as the EMT process via downregulating the expression of ITGB4 in ccRCC. Here, AKT1 is linked to nonpapillary renal cell carcinoma.